The short version of anti-doping fits in a sentence. The long version — which is the one that helps — is below.
Reviewed 2025-11-07. Anything still debated is marked as such rather than presented as settled.
In the scientific literature, AOD-9604 appears in reviews of growth hormone fragments and in discussions of peptide-based metabolic research. Some sources distinguish it from growth hormone itself, while others group it with compounds marketed for weight management. The evidence base is small compared with approved obesity medications. Questions about long-term efficacy and clinical relevance remain open, and independent replication of key findings is limited. Most published reports are early-stage and exploratory.
AOD-9604 is a synthetic peptide modeled on the C-terminal region of human growth hormone. It is often described as hGH fragment 176-191. Research interest arose because it was designed to isolate possible effects on fat metabolism from other actions of growth hormone. It is not a full growth hormone molecule. Its development history includes early laboratory and animal studies followed by human trials. The peptide has been examined in laboratory, animal, and limited human studies.
Regulatory bodies have taken different approaches to AOD-9604. It is not approved as a prescription medicine by major agencies such as the U.S. Food and Drug Administration or the European Medicines Agency. In sport, the World Anti-Doping Agency prohibits peptide hormones, growth factors, and related substances, and AOD-9604 has been treated as a prohibited substance. These regulatory decisions reflect concerns about safety, efficacy, and potential misuse rather than proof of benefit.
Research on AOD-9604 also examines how the peptide is measured in biological samples. Analytical methods may include liquid chromatography coupled with mass spectrometry, immunoassays, or both. Detection can be challenging because the peptide is small and may be present at low concentrations. Published methods vary in sensitivity and specificity, so comparative interpretation requires attention to validation details. The presence of related hGH fragments can complicate identification in some matrices.
AOD-9604 has been investigated mainly in the context of body fat and metabolic endpoints. Some early animal and small human studies reported changes in fat mass or lipid markers, but findings were not uniform. Larger, well-controlled trials that would establish efficacy are lacking in the public literature. As a result, claims about weight loss or metabolic benefit remain investigational rather than established. The distinction between a research finding and a proven clinical outcome is central to discussing this peptide.
| Property | Value | Notes |
|---|---|---|
| Common synonym | hGH fragment 176-191 | Refers to the C-terminal segment |
| Appearance | White to off-white powder | Typically supplied lyophilized |
| Solubility | Soluble in water and aqueous buffers | Confirm with technical data |
| Typical storage temperature | -20 °C for dry powder | Protect from moisture and light |
| Common analytical method | RP-HPLC with UV detection | Often paired with mass spectrometry |
=== Apodization in astronomy === Apodization is used in telescope optics to improve the dynamic range of the image. For example, stars with low intensity in the close vicinity of very bright stars can be made visible using this technique, and even images of planets can be obtained when otherwise obscured by the bright atmosphere of the star they orbit. Generally, apodization reduces the resolution of an optical image; however, because it reduces diffraction edge effects, it can actually enhance certain small details. In fact, the notion of resolution, as it is commonly defined with the Rayleigh criterion, is in this case partially irrelevant. One has to understand that the image formed in the focal plane of a lens (or a mirror) is modeled through the Fresnel diffraction formalism. The classical diffraction pattern, the Airy disk, is connected to a circular pupil, without any obstruction, and with a uniform transmission. Any change in the shape of the pupil (for example a square instead of a circle), or its transmission, results in an alteration to the associated diffraction pattern.
On August 28, 1907, James E. Casey founded the American Messenger Company with Claude Ryan in Seattle, Washington, capitalized with $100 in debt. Most deliveries at this time were made on foot and bicycles (later streetcars) were used for longer trips. The company received telephone calls for its deliveries. The American Messenger Company focused primarily on package delivery to retail stores with special delivery mail coming into Seattle for its largest client, the United States Post Office Department—the predecessor of today's United States Postal Service. Due to improvements in telephony and in the auto industry, demand for messenger service declined. The company addressed this by shifting focus to package delivery for retail stores. In 1913, the company acquired a Ford Model T as its first delivery vehicle. Casey and Ryan merged with a competitor, Evert McCabe, and formed Merchants Parcel Delivery. Consolidated delivery was also introduced, combining packages addressed to a certain neighborhood onto one delivery vehicle. In 1916, Charlie Soderstrom joined Merchants Parcel Delivery bringing in more vehicles for the growing delivery business. In 1919, the company expanded for the first time outside of Seattle to Oakland, California, and changed its name to United Parcel Service. The common carrier service was acquired in 1922 from a company in Los Angeles, California. UPS became one of the only companies in the United States to offer common carrier service.
Other religions in India (and population in the 2011 census) are Sarnaism (4.96 million) and Gondi-Koyapunem (1.03 million) and Sari dharma (510,000). In 1951—India's first postcolonial census—the percentage breakdown of India's religions was: Hindu (84.1%), Muslims (9.8%), Christians (2.3%), Sikhs (1.9%), Buddhists (0.7%) and Jains (0.5%); sixty years later, in India's last census (2011), the percentages were: Hindus (79.8%), Muslims (14.2%), Christians (2.3%), Sikhs (1.7%), Buddhists (0.7%) and Jains (0.4%) In absolute numbers, during the period 1951–2011, India's religious groups grew in the following manner: Hindus (304 million to 966 million), Muslims (35 million to 172 million), Christians (8.3 million to 28 million), Sikhs (6.82 million to 20.83 million), Buddhists (2.67 million to 8.44 million) and Jains (1.66 million to 4.45 million). In the decade 1951–1961, the population growth by religions was: Hindus (20.7%), Muslims (32.7%), Christians (29%), Sikhs (10.3%), Buddhists (5.9%), Jains (3.7%); in the decade 2001–2011, the growth was: Hindus (16.7%), Muslims (24.7%), Christians (15.7%), Sikhs (16.1%), Buddhists (4.8%), and Jains (2.2%). All religions have registered declining growth rates. Birth rates, population growth, and access to education influence how communities mobilise politically to preserve their places of worship, to manage charitable trusts, and to protect their family laws. Differences in states' laws, especially those prohibiting religious conversion—usually from Hinduism to other faiths—colour the daily lives of minority communities.
=== Viewpoints modeling and the RM-ODP framework === Most complex system specifications are so extensive that no single individual can fully comprehend all aspects of the specifications. Furthermore, we all have different interests in a given system and different reasons for examining the system's specifications. A business executive will ask different questions of a system make-up than would a system implementer. The concept of RM-ODP viewpoints framework, therefore, is to provide separate viewpoints into the specification of a given complex system. These viewpoints each satisfy an audience with interest in a particular set of aspects of the system. Associated with each viewpoint is a viewpoint language that optimizes the vocabulary and presentation for the audience of that viewpoint. Viewpoint modeling has become an effective approach for dealing with the inherent complexity of large distributed systems. Current software architectural practices, as described in IEEE 1471, divide the design activity into several areas of concerns, each one focusing on a specific aspect of the system. Examples include the "4+1" view model, the Zachman Framework, TOGAF, DoDAF and, of course, RM-ODP. A viewpoint is a subdivision of the specification of a complete system, established to bring together those particular pieces of information relevant to some particular area of concern during the analysis or design of the system. Although separately specified, the viewpoints are not completely independent; key items in each are identified as related to items in the other viewpoints.
Sources: en.wikipedia.org
==== Phenibut ==== Phenibut (Anvifen, Fenibut, Noofen) is an anxiolytic used in Russia. Phenibut is a GABAB receptor agonist, as well as an antagonist at α2δ subunit-containing voltage-dependent calcium channels (VDCCs), similarly to gabapentinoids like gabapentin and pregabalin. The medication is not approved by the FDA for use in the United States, but is sold online as a supplement.
== Medical uses == Lurbinectedin is indicated for the treatment of adults with metastatic small cell lung cancer with disease progression on or after platinum-based chemotherapy. In October 2025, the indication for lurbinectedin was expanded to include using lurbinectedin in combination with atezolizumab or in combination with atezolizumab/hyaluronidase for the maintenance treatment of adults with extensive-stage small cell lung cancer whose disease has not progressed after first-line induction therapy with atezolizumab or atezolizumab and hyaluronidase, carboplatin, and etoposide.
===== Hymenopterans ===== Wasps and hornets have serotonin in their venom, which causes pain and inflammation as do scorpions. Pheidole dentata takes on more and more tasks in the colony as it gets older, which requires it to respond to more and more olfactory cues in the course of performing them. This olfactory response broadening was demonstrated to go along with increased serotonin and dopamine, but not octopamine in 2006.
Sources: en.wikipedia.org
== Activating and inhibiting agents == The SC-FAs that activate FFAR3 include proprionic, butyric, acetic, valeric caproic, and formic acids. (Confusingly, butyric acid also activates hydroxycarboxylic acid receptor 2 and β-hydroxybutyric acid has been reported to stimulate or inhibit FFAR3.) FFAR2 is activated by many of these same SC-FAs but differs from FFAR3 in its relative binding affinities for them. In humans, the binding affinity ranking of FFAR3 is: propionic = butyric = valeric > acetic > formic acids (acetic and formic acids have very low binding affinities for, and therefore must be at extremely high levels to activate, FFAR3); FFAR2's relative binding affinity ranking for these SC-FAs is: acetic = propionic > butyric > valeric = formic acids. AR420626 (a derivative of an older compound 1-MCPC) has been reported to be a selective activator of FFAR3 but has also been reported to inhibit the activation of FFAR3. Its actions require further characterizations. AR399519 and CF3-MQC have been reported to inhibit the activation of mouse FFAR3; the actions of these agents also require further characterizations.
Though a good signal may be achieved through glycerol or glycerol with an additive, there could be other matrix compounds that can offer an even better signal. Optimization of matrix compounds and concentration of solid analyte are vital for FAB measurements.
The NRD pathway for the 40S subunit may be independent or separate from the NRD pathway for the 60S subunit. It has been observed that certain genes were able to affect degradation of certain pre-RNAs, but not others. Numerous proteins are involved in the NRD pathway, such as Mms1p and Rtt101p, which are believed to complex together to target ribosomes for degradation. Mms1p and Rtt101p are found to bind together and Rtt101p is believed to recruit a ubiquitin E3 ligase complex, allowing for the non-functional ribosomes to be ubiquinated before being degraded. Prokaryotes lack a homolog for Mms1, so it is unclear how prokaryotes are able to degrade non-functional rRNAs. The growth rate of eukaryotic cells did not seem to be significantly affected by the accumulation of non-functional rRNAs.
Sources: en.wikipedia.org
It is a synthetic peptide fragment derived from the C-terminal region of human growth hormone, commonly referred to as hGH fragment 176-191. It has been investigated for effects on fat metabolism, but it is not an approved medication in most jurisdictions.
No. It is a shortened peptide fragment, not the full hormone. It does not contain the entire hGH sequence and is studied for different proposed effects.
Regulatory approvals for weight loss are not established in major jurisdictions. Some human trials reported modest changes, but the evidence is limited, and it remains a research compound.
No. It is not approved as a therapeutic drug by major regulators. It is sold for research purposes in many settings, which is not the same as clinical approval.